Related references
Note: Only part of the references are listed.Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
Jim Gilbert et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Genetic Deletion of Chemokine Receptor Ccr6 Decreases Atherogenesis in ApoE-Deficient Mice
Wuzhou Wan et al.
CIRCULATION RESEARCH (2011)
Chemokine research moves on
Ann Richmond
EXPERIMENTAL CELL RESEARCH (2011)
Heterophilic chemokine receptor interactions in chemokine signaling and biology
Birgit K. Kramp et al.
EXPERIMENTAL CELL RESEARCH (2011)
Chemokines as mediators of tumor angiogenesis and neovascularization
Ellen C. Keeley et al.
EXPERIMENTAL CELL RESEARCH (2011)
Effect of posttranslational processing on the in vitro and in vivo activity of chemokines
Anneleen Mortier et al.
EXPERIMENTAL CELL RESEARCH (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function
C. L. Salanga et al.
EXPERIMENTAL CELL RESEARCH (2011)
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
Christian Weber et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression
Stephane Potteaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Israel F. Charo et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Dose-Response Met-RANTES Treatment of Experimental Periodontitis: A Narrow Edge between the Disease Severity Attenuation and Infection Control
Carlos Eduardo Repeke et al.
PLOS ONE (2011)
Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans
Norbert Gerdes et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation
S. Ali et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice
Fabrizio Montecucco et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE-/- mice
Robert J. Aiello et al.
ATHEROSCLEROSIS (2010)
Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis
Ana L. Gomes et al.
BLOOD (2010)
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Dirk Lievens et al.
BLOOD (2010)
Chemokines in the vascular inflammatory response of atherosclerosis
Alma Zernecke et al.
CARDIOVASCULAR RESEARCH (2010)
Chemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development
Maren Luchtefeld et al.
CIRCULATION (2010)
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Maik Drechsler et al.
CIRCULATION (2010)
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme
Min Ren et al.
EMBO JOURNAL (2010)
Endothelial Heparan Sulfate Controls Chemokine Presentation in Recruitment of Lymphocytes and Dendritic Cells to Lymph Nodes
Xingfeng Bao et al.
IMMUNITY (2010)
Rationally Evolving MCP-1/CCL2 into a Decoy Protein with Potent Anti-inflammatory Activity in Vivo
Anna Maria Piccinini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Marie-Luise Berres et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice
Vincent Braunersreuther et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
A New Monocyte Chemotactic Protein-1/Chemokine CC Motif Ligand-2 Competitor Limiting Neointima Formation and Myocardial Ischemia/Reperfusion Injury in Mice
Elisa A. Liehn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Therapeutic targeting of chemokine interactions in atherosclerosis
Rory R. Koenen et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection
Erbin Dai et al.
PLOS ONE (2010)
Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus
Hu Hu et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Phagocyte partnership during the onset and resolution of inflammation
Oliver Soehnlein et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to Atherosclerosis
Emmanuel L. Gautier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Limor Landsman et al.
BLOOD (2009)
Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12
Graeme O'Boyle et al.
FASEB JOURNAL (2009)
Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of Selective Antagonists
Denis Sohy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
'Cellular dysfunction in inflammatory-related vascular disorders' Review Series The inflammatory process: a new dimension of a 19th century old story
Maya Simionescu
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
An engineered CX3CR1 antagonist endowed with anti-inflammatory activity
Karim Dorgham et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity
Monika Pruenster et al.
NATURE IMMUNOLOGY (2009)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
OPINION Chemokine receptor antagonists: overcoming developmental hurdles
Richard Horuk
NATURE REVIEWS DRUG DISCOVERY (2009)
Platelet-Mediated Enhancement of Leukocyte Adhesion
Philipp Von Hundelshausen et al.
MICROCIRCULATION (2009)
Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3
Joao M. Dias et al.
PLOS ONE (2009)
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice
Eva J. A. Van Wanrooij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis
Alma Zernecke et al.
CIRCULATION RESEARCH (2008)
Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo
O. Postea et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Ticks produce highly selective chemokine binding proteins with antiinflammatory activity
Maud Deruaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients
Jacob Lalezari et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo
Tracy M. Handel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury
E. Karshovska et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
Hubert Gaertner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CXCR4-CCR5: A couple modulating T cell functions
Rita Lucia Contento et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CCR7 and its ligands:: balancing immunity and tolerance
Reinhold Foerster et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2008)
CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration
Yafa Naim et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The Novel CXCL12γ Isoform Encodes an Unstructured Cationic Domain Which Regulates Bioactivity and Interaction with Both Glycosaminoglycans and CXCR4
Cedric Laguri et al.
PLOS ONE (2007)
CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-γ production, and macrophage accumulation in the aortic wall
Elena Galkina et al.
CIRCULATION (2007)
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells
Martin A. Schneider et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites
Chia-Lin Tsou et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis
Adi Mor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity
Gabriele S. V. Campanella et al.
JOURNAL OF IMMUNOLOGY (2006)
Heparin displaces interferon-γ-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells
Hooman Ranjbaran et al.
CIRCULATION (2006)
Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis
Ara M. Aslanian et al.
CIRCULATION (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells
Eric A. Heller et al.
CIRCULATION (2006)
Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression
WA Boisvert et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice
E Trogan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
NV Serbina et al.
NATURE IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella et al.
NATURE MEDICINE (2006)
Chemokine blockers - therapeutics in the making?
TNC Wells et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice
EJA van Wanrooij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity
P Smith et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Engineering novel binding proteins from nonimmunoglobulin domains
HK Binz et al.
NATURE BIOTECHNOLOGY (2005)
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses
LC Wang et al.
NATURE IMMUNOLOGY (2005)
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo
NR Veillard et al.
CIRCULATION (2005)
Gene profiling in atherosclerosis reveals a key role for small inducible cytokines - Validation using a novel monocyte chemoattractant protein monoclonal antibody
E Lutgens et al.
CIRCULATION (2005)
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
P von Hundelshausen et al.
BLOOD (2005)
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice
NR Veillard et al.
CIRCULATION RESEARCH (2004)
Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD - A pilot study
DA Mahler et al.
CHEST (2004)
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
M Navab et al.
JOURNAL OF LIPID RESEARCH (2004)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence
C Martin et al.
IMMUNITY (2003)
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
AEI Proudfoot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3
P Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury
A Schober et al.
CIRCULATION (2002)
Chemokine receptor expression on MBP-reactive T cells:: CXCR6 is a marker of IFN-γ-producing effector cells
PA Calabresi et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Early application of Met-RANTES ameliorates chronic allograft nephropathy
EW Song et al.
KIDNEY INTERNATIONAL (2002)
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat
MN Ajuebor et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
